CCS/HLS Atherosclerosis Research Award
The Canadian Cardiovascular Society and HLS Therapeutics are proud to support the CCS/HLS Atherosclerosis Research Award. This research award will support innovative groundbreaking clinical research projects in the area of atherosclerosis. Priority will be given to research that has the potential to advance clinical knowledge of atherosclerosis process linked to inflammation, membrane stability and biomarkers.
This Award is intended for Canadian MDs in the first 5 years of their first clinical appointment in an academic department for a research project on the topic of atherosclerosis.
Two (2) awards of $15,000 each will be awarded based on an independent peer review process.
Application Deadline EXTENDED: Monday, September 20th, 2021 at 11:59 AM EST.